IL68306A - Esters of cyproheptadine-3-carboxylic acid and related compounds,their preparation and pharmaceutical compositions containing them - Google Patents
Esters of cyproheptadine-3-carboxylic acid and related compounds,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL68306A IL68306A IL68306A IL6830683A IL68306A IL 68306 A IL68306 A IL 68306A IL 68306 A IL68306 A IL 68306A IL 6830683 A IL6830683 A IL 6830683A IL 68306 A IL68306 A IL 68306A
- Authority
- IL
- Israel
- Prior art keywords
- emesis
- esters
- dyspepsia
- cyproheptadine
- carboxylic acid
- Prior art date
Links
- 150000002148 esters Chemical class 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010047700 Vomiting Diseases 0.000 abstract 4
- 201000006549 dyspepsia Diseases 0.000 abstract 3
- 102000015554 Dopamine receptor Human genes 0.000 abstract 2
- 108050004812 Dopamine receptor Proteins 0.000 abstract 2
- 206010028813 Nausea Diseases 0.000 abstract 2
- 230000008693 nausea Effects 0.000 abstract 2
- 230000000638 stimulation Effects 0.000 abstract 2
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 206010021518 Impaired gastric emptying Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000031649 Postoperative Nausea and Vomiting Diseases 0.000 abstract 1
- 108091008690 chemoreceptors Proteins 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000003210 dopamine receptor blocking agent Substances 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000000291 postprandial effect Effects 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/368,257 US4412999A (en) | 1982-04-14 | 1982-04-14 | Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL68306A0 IL68306A0 (en) | 1983-07-31 |
| IL68306A true IL68306A (en) | 1986-09-30 |
Family
ID=23450498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL68306A IL68306A (en) | 1982-04-14 | 1983-04-06 | Esters of cyproheptadine-3-carboxylic acid and related compounds,their preparation and pharmaceutical compositions containing them |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4412999A (pt) |
| EP (1) | EP0092114B1 (pt) |
| JP (1) | JPS58188879A (pt) |
| KR (1) | KR880002042B1 (pt) |
| AT (1) | ATE30589T1 (pt) |
| AU (1) | AU556530B2 (pt) |
| CA (1) | CA1203798A (pt) |
| DE (1) | DE3374312D1 (pt) |
| DK (1) | DK161983A (pt) |
| ES (1) | ES8404686A1 (pt) |
| GR (1) | GR78832B (pt) |
| IE (1) | IE55033B1 (pt) |
| IL (1) | IL68306A (pt) |
| NZ (1) | NZ203786A (pt) |
| PT (1) | PT76501B (pt) |
| ZA (1) | ZA832589B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522821A (en) * | 1982-04-14 | 1985-06-11 | Merck & Co., Inc. | Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds |
| US4501749A (en) * | 1983-10-31 | 1985-02-26 | Merck & Co., Inc. | Peripherally selective dopamine antagonists in the treatment of ocular hypertension |
| GB8520662D0 (en) * | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| CA2025398A1 (en) * | 1989-09-20 | 1992-03-15 | Timothy Gerard Dinan | Diagnosis and treatment of a disorder of the gastrointestinal tract |
| FR2877573B1 (fr) * | 2004-11-05 | 2007-02-02 | Debussy Holding Sa | Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues |
| EP2067777B1 (en) | 2006-09-29 | 2013-08-14 | Nippon Zoki Pharmaceutical Co., Ltd. | Oxepin derivative |
| CA2893427C (en) | 2012-12-24 | 2023-01-10 | Neurogastrx, Inc. | Methods for treating gi tract disorders |
| US9844554B2 (en) | 2014-06-24 | 2017-12-19 | Neurogastrx, Inc. | Prodrugs of metopimazine |
| US10836757B1 (en) | 2020-04-02 | 2020-11-17 | Neurogastrx, Inc. | Polymorphic forms of metopimazine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3014911A (en) * | 1958-09-29 | 1961-12-26 | Merck & Co Inc | Derivatives of dibenzo[a, e]cycloheptatriene |
| NL125839C (pt) * | 1963-12-03 | |||
| US3981877A (en) * | 1972-08-14 | 1976-09-21 | Merck & Co., Inc. | Piperidylidene derivatives of carboxy-5H-dibenzo[a,d]cycloheptene |
| US4072756A (en) * | 1973-05-17 | 1978-02-07 | Sandoz Ltd. | Tricyclo piperidino ketones and soporific compositions thereof |
| US4086350A (en) * | 1974-11-06 | 1978-04-25 | Smithkline Corporation | Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms |
| NL173398C (nl) * | 1974-11-11 | Merck & Co Inc | Werkwijze ter bereiding van farmaceutische preparaten alsmede werkwijze ter bereiding van een aan een benzeenkern gesubstitueerd 1-methyl-4-(10,11-dihydro-5h-dibenzo (a,d)cyclohepten-5-ylideen)-piperidinederivaat. | |
| US4076714A (en) * | 1974-11-25 | 1978-02-28 | Merck & Co., Inc. | 1-Methyl-4-(2-carboxy-thioxanthen-9-ylidene)-piperidine an appetite stimulant and antihistaminic agent |
| US4160031A (en) * | 1975-03-28 | 1979-07-03 | Merck & Co., Inc. | Antihistaminic and appetite stimulating 10,11-dihydro-3-carboxycyproheptadine |
| US4066772A (en) * | 1975-07-21 | 1978-01-03 | Janssen Pharmaceutica N.V. | 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds |
-
1982
- 1982-04-14 US US06/368,257 patent/US4412999A/en not_active Expired - Fee Related
-
1983
- 1983-04-05 PT PT76501A patent/PT76501B/pt unknown
- 1983-04-06 IL IL68306A patent/IL68306A/xx unknown
- 1983-04-06 NZ NZ203786A patent/NZ203786A/en unknown
- 1983-04-06 AU AU13188/83A patent/AU556530B2/en not_active Ceased
- 1983-04-07 EP EP83103380A patent/EP0092114B1/en not_active Expired
- 1983-04-07 AT AT83103380T patent/ATE30589T1/de not_active IP Right Cessation
- 1983-04-07 DE DE8383103380T patent/DE3374312D1/de not_active Expired
- 1983-04-11 GR GR71048A patent/GR78832B/el unknown
- 1983-04-11 CA CA000425633A patent/CA1203798A/en not_active Expired
- 1983-04-11 ES ES521359A patent/ES8404686A1/es not_active Expired
- 1983-04-12 IE IE833/83A patent/IE55033B1/en unknown
- 1983-04-13 KR KR1019830001539A patent/KR880002042B1/ko not_active Expired
- 1983-04-13 ZA ZA832589A patent/ZA832589B/xx unknown
- 1983-04-13 DK DK161983A patent/DK161983A/da not_active IP Right Cessation
- 1983-04-14 JP JP58064665A patent/JPS58188879A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ZA832589B (en) | 1984-11-28 |
| NZ203786A (en) | 1985-11-08 |
| ATE30589T1 (de) | 1987-11-15 |
| EP0092114A2 (en) | 1983-10-26 |
| DE3374312D1 (en) | 1987-12-10 |
| PT76501A (en) | 1983-05-01 |
| KR880002042B1 (ko) | 1988-10-13 |
| US4412999A (en) | 1983-11-01 |
| PT76501B (en) | 1986-02-06 |
| ES521359A0 (es) | 1984-05-16 |
| EP0092114A3 (en) | 1985-01-16 |
| DK161983A (da) | 1983-10-15 |
| IL68306A0 (en) | 1983-07-31 |
| AU556530B2 (en) | 1986-11-06 |
| KR840004422A (ko) | 1984-10-15 |
| ES8404686A1 (es) | 1984-05-16 |
| JPS58188879A (ja) | 1983-11-04 |
| GR78832B (pt) | 1984-10-02 |
| EP0092114B1 (en) | 1987-11-04 |
| AU1318883A (en) | 1983-10-20 |
| CA1203798A (en) | 1986-04-29 |
| IE55033B1 (en) | 1990-05-09 |
| DK161983D0 (da) | 1983-04-13 |
| IE830833L (en) | 1983-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL68306A (en) | Esters of cyproheptadine-3-carboxylic acid and related compounds,their preparation and pharmaceutical compositions containing them | |
| NO1994011I1 (no) | Cisaprid | |
| GR3022433T3 (en) | Cinnoline-3-carboxylic acid derivatives as 5-HT3 antagonists | |
| DE3585990D1 (de) | Derivate von hydroxy- oder amino-substituierten piperidinylalkylchinazolinen. | |
| GB1242160A (en) | Isoquinolines | |
| US2718488A (en) | Amine salts of fumagillin | |
| GB1339010A (en) | Tetrazolyl-anthraquinone derivatives | |
| ES419587A1 (es) | Procedimiento para la preparacion de composiciones de apli- cacion en veterinaria. | |
| GB1316674A (en) | 1-disubstituted-amino pyrazoles and the production thereof | |
| JPS5273864A (en) | Preparation of novel carboxylic acid amide derivative | |
| CA195230A (en) | Fence post | |
| CA188067A (en) | Fence post | |
| CA186805A (en) | Fence post | |
| CA184813A (en) | Fence post | |
| CA184560A (en) | Fence post | |
| ES261963A1 (es) | Procedimiento de preparaciën de nuevos derivados del iminodibencilo | |
| ES385700A2 (es) | Procedimiento para la preparacion de nuevos acidos carboxi-licos heterociclicos. | |
| GB116024A (en) | New or Improved Food Compound or Mixture. | |
| GB1211174A (en) | Thienopyridine derivatives | |
| GB794159A (en) | Substituted piperidine-4-carboxylic esters | |
| GB1081743A (en) | 3,3-bis(p-hydroxyphenyl) oxindole | |
| GB1060082A (en) | Phenoxyalkylisothiosemicarbazides |